Practice Protocol
Build an agreement

Protocol · PharmD · Connecticut

Practice Protocol for Pharmacists in Connecticut

Required. Connecticut law names the instrument a Collaborative Drug Therapy Management Agreement or Care Plan, and the clinical protocol is the content that instrument carries. Below: the board that governs it, what it must contain, and the terms it has to carry.

Practice authoritySupervision required
Written agreementAgreement required
What Connecticut calls itCollaborative Drug Therapy Management Agreement or Care Plan
Governing boardConnecticut Commission of Pharmacy
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Represents Connecticut's pharmacist Collaborative Drug Therapy Management (CDTM) framework (§20-631), not ordinary licensure — base dispensing/counseling need no physician/APRN agreement and are out of scope here. Any 'qualified pharmacist' (competency requirement plus review of the national Pharmacists' Patient Care Process) may enter a CDTM agreement; no residency, board-certification, or numeric per-prescriber cap was found.

What a Connecticut Collaborative Drug Therapy Management Agreement or Care Plan must contain

Governed by the Connecticut Commission of Pharmacy. Each numbered item is a statutory requirement the Collaborative Drug Therapy Management Agreement or Care Plan must satisfy.

  1. The Pharmacist may practice under a collaborative drug therapy management agreement or care plan with the Physician, as authorized under Conn. Gen. Stat. § 20-631. Only a "qualified pharmacist" — one whom regulations of the Connecticut Department of Public Health deem competent, and who has reviewed the Pharmacists' Patient Care Process published by the Joint Commission of Pharmacy Practitioners — may serve as the collaborating pharmacist under such an agreement.

    Source: Conn. Gen. Stat. § 20-631

  2. The Collaborative Drug Therapy Management Agreement or Care Plan also carries 1 scope, 1 education, 1 registration and 1 authority clauses, authored in the document itself.

Terms it has to carry

Ratio, proximity, chart review, meeting and prescribing terms the Collaborative Drug Therapy Management Agreement or Care Plan has to carry, from Connecticut's supervision rules.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Covered by the practice agreement · no controlled-substance authority

Section 20-631's CDTM authority does not mention controlled substances, so the entry treats Schedule II–V drugs as outside CDTM by statutory silence rather than by an express exclusion. The pharmacist must notify the prescribing practitioner within 24 hours of any discontinuance or deprescribing.

Written agreement

Required

The prescribing practitioner (physician or APRN) must first establish a provider-patient relationship with the patient before the pharmacist may act under a CDTM agreement, care plan, or institutional CDTM policy (§20-631(b)).

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — No general pharmacist-ownership requirement — a pharmacy must be 'supervised and managed' by a full-time pharmacist-manager (§20-597), who retains professional control over dispensing, but the pharmacy itself may be non-pharmacist/corporate-owned.

One CT-specific restriction: no prescribing practitioner, their spouse (unless also a pharmacist), or their dependent child may hold an ownership/investment interest in a pharmacy (§20-596) — an anti-self-referral rule distinct from the CDTM clinical framework above.

Sources for the supervision rules (4)
How the relationship works day to day
Who has to be where, how often you meet, and what the physician costs: Pharmacist in Connecticut on collaborativeagreement.com.

About Connecticut's rules

NP, CNS, and CRNA are all licensed as a single 'advanced practice registered nurse' category (§20-94a) sharing an identical 3-year/2,000-hour collaboration-to-independence pathway (§20-87a); CT does not statutorily distinguish PMHNP or CNS scope from general NP. CNMs are licensed separately (Ch. 377), with no written collaborative-agreement requirement. No provider type below has a codified supervision ratio cap, chart-review percentage, or on-site proximity radius outside CRNA's surgery-specific carve-out.

Other clinicians in Connecticut: see the state overview.